Biotechnology
Prolifagen LLC, a 2016 virtual spin off company from University of Pennsylvania located in the Philadelphia area, is focusing on pre-clinical and early clinical development of a groundbreaking, microRNA-based approach to regeneration of damaged organs without the use of exogenous stem cells.